Biomedical Technologies, Inc.

BTI is a manufacturer. EGF, ,ECGS,Fibronectin,Laminin,Collagen,cyclicAMP EIA and RIA kits, EGF EIA kit, Lysozyme EIA kit, Osteocalcin EIA & RIA kits, TGF-alpha EIA, LDL, HDL, OxLDL, mOxLDL,AcLDL,DiIAcLDL, DiILDL, DiOLDL, [I-125]Lipoproteins,LPDS,THG, anti-Involucrin, anti-bFGF, anti-Myosin, anti-Actin, anti-LDL, anti cyclicAMP, anti-Osteocalcin, Apolipoprotein AI and AII, etc.

Activity:

- Manufacturing
- Research & Development

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Diagnostics
- Enzymes
- Proteins
- Reagents
- Technology

Therapeutic targets:

- Cardiovascular
- Dermatology

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America , Europe , Asia , Australia/New-Zealand

c. Countries active: USA and Canada

Corporate data:

Number of Employees: <100

Turnover:

Amount:	Year:	Currency:
<10,000,000.	2002	US Dollar

Year founded: 1981